cancer cachexia

Also found in: Dictionary, Thesaurus, Encyclopedia.

Related to cancer cachexia: paraneoplastic syndrome

A complex, multifactorial syndrome characterised by anorexia and/or unintended loss of appetite, accompanied by generalized host tissue wasting, skeletal muscle atrophy, immune dysfunction, and metabolic derangements

cancer cachexia

Oncology A complex, multifactorial syndrome characterized by anorexia and/or unintended loss of appetite, accompanied by generalized host tissue wasting, skeletal muscle atrophy, immune dysfunction, and metabolic derangements. See Cachexia, Malnutrition.

Mentioned in ?

References in periodicals archive ?

The report reviews key players involved in the therapeutics development for Cancer Cachexia and enlists all their major and minor projects

Cancer Cachexia - Pipeline Review, H2 2015 - New Study Released

In the present study, we evaluate the effect of parthenolide for the treatment of cancer cachexia in a cancer cachexia model by subcutaneously grafted CT26 tumor fragments into BALB/c mice.

Parthenolide from Parthenium integrifolium reduces tumor burden and alleviate cachexia symptoms in the murine CT-26 model of colorectal carcinoma

Decrease of serum carnitine levels in patients with or without gastrointestinal cancer cachexia.

Carnitine restores cellular function

An energy and protein dense, high n-3 fatty acid oral supplement promotes weight gain in cancer cachexia.

Understanding tumor-induced weight loss

Several pieces of evidence suggest a key role for ROS in the development of muscle atrophy in response to the inflammatory profile related to cancer cachexia [10,11].

The Janus-Faced Role of Antioxidants in Cancer Cachexia: New Insights on the Established Concepts

A snapshot of the global therapeutic scenario for Cancer Cachexia.

Recently released market study: Cancer Cachexia - Pipeline Review, H1 2013

BB:OHRP) has enrolled the first three patients at a new clinical site in its ongoing Phase 2b clinical trial to investigate the efficacy of OHR/AVR118 for the treatment of cancer cachexia in patients with recurrent or advanced cancers.

Ohr Pharmaceutical announces enrolment of first three patients for ongoing Phase 2b Cachexia trial

The researchers wanted to find the dominant pathway responsible for cancer cachexia, and then design a way to block it in order to treat patients.

Drug to reverse muscle loss due to cancer created

In cancer cachexia, this "labeling" system becomes overactive and results in accelerated muscle protein breakdown.

Exercise is medicine: resistance exercise for cachexia

Unlike conventional cancer management, the Block Center's foundational program targets one of the most serious consequences of the disease, known as cancer cachexia.

Integrative cancer care at the block center

The purpose of these guidelines is to provide dietitians in Australia with a user-friendly summary of the evidence to support the nutritional management of adult patients with cancer cachexia.

Evidence based practice guidelines for the nutritional management of cancer cachexia